C. H. van Dyck, M.D. July 23, 2012 CURRICULUM VITAE Christopher H. van Dyck, M.D.

First Page		Document Content
Date: 2012-07-23 05:46:28 Health Design of experiments Pharmacology Evaluation methods Epidemiology Clinical trial Placebo-controlled study Mild cognitive impairment Scyllo-Inositol Clinical research Science Research		C. H. van Dyck, M.D. July 23, 2012 CURRICULUM VITAE Christopher H. van Dyck, M.D. Add to Reading List Source URL: yale-faculty.photobooks.com Download Document from Source Website File Size: 264,50 KB Share Document on Facebook

	Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura Marie Scully, Spero Cataland, Flora Peyvandi, Paul Coppo, DocID: 1utac - View Document
	Clin Exp Allergy 2002; 32:928±932 A double-blind, placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects M. Semizzi, G. Senna, M. Crivellaro, G. Rapacioli{, G. Passalacqua{, DocID: 1t7cl - View Document
	A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with HRD-Positive Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemothe DocID: 1rDJY - View Document
	Press release from the International Council for Homeopathy ICH is the international professional platform representing the interests of 32 national associations of professional homeopathy practitioners in 30 Countries DocID: 1qj7u - View Document
	TRIUMPH I study: Double Blind Placebo Controlled Clinical Investigation into the Efficacy and Tolerability of Inhaled Treprostinil Sodium in Patients with Severe Pulmonary Arterial Hypertension DocID: 1oueC - View Document